Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ)
CNY 5.52
(-0.18%)
CNY 5.52
(-0.18%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 251.76 Million CNY | -33.63% |
| 2022 | 300.36 Million CNY | 1.49% |
| 2021 | 295.95 Million CNY | 15.58% |
| 2020 | 256.07 Million CNY | -9.11% |
| 2019 | 281.74 Million CNY | -12.71% |
| 2018 | 322.76 Million CNY | 1.61% |
| 2017 | 317.64 Million CNY | 7.93% |
| 2016 | 294.29 Million CNY | -25.27% |
| 2015 | 393.79 Million CNY | 18.61% |
| 2014 | 332.01 Million CNY | 52.99% |
| 2013 | 217.02 Million CNY | 9.8% |
| 2012 | 197.65 Million CNY | 27.2% |
| 2011 | 155.38 Million CNY | 29.25% |
| 2010 | 120.22 Million CNY | 39.67% |
| 2009 | 86.07 Million CNY | 39.11% |
| 2008 | 61.87 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 39.19 Million CNY | -17.69% |
| 2024 Q3 | 47.68 Million CNY | 21.64% |
| 2024 Q1 | 47.62 Million CNY | -13.56% |
| 2023 Q1 | 61.07 Million CNY | -4.23% |
| 2023 Q4 | 55.09 Million CNY | -14.44% |
| 2023 FY | 199.36 Million CNY | -33.63% |
| 2023 Q3 | 64.39 Million CNY | -2.99% |
| 2023 Q2 | 66.38 Million CNY | 8.69% |
| 2022 FY | 300.36 Million CNY | 1.49% |
| 2022 Q3 | 81.64 Million CNY | -0.83% |
| 2022 Q4 | 63.77 Million CNY | -21.89% |
| 2022 Q1 | 72.61 Million CNY | -5.57% |
| 2022 Q2 | 82.32 Million CNY | 13.38% |
| 2021 Q4 | 76.89 Million CNY | -9.17% |
| 2021 Q1 | 62.54 Million CNY | -19.78% |
| 2021 Q2 | 71.85 Million CNY | 14.89% |
| 2021 Q3 | 84.65 Million CNY | 17.82% |
| 2021 FY | 295.95 Million CNY | 15.58% |
| 2020 FY | 256.07 Million CNY | -9.11% |
| 2020 Q4 | 77.96 Million CNY | -7.93% |
| 2020 Q3 | 84.68 Million CNY | 25.63% |
| 2020 Q2 | 67.4 Million CNY | 159.06% |
| 2020 Q1 | 26.01 Million CNY | -68.68% |
| 2019 FY | 281.74 Million CNY | -12.71% |
| 2019 Q4 | 83.07 Million CNY | 35.09% |
| 2019 Q3 | 61.49 Million CNY | -23.1% |
| 2019 Q2 | 79.96 Million CNY | 39.79% |
| 2019 Q1 | 57.2 Million CNY | -13.84% |
| 2018 Q2 | 89.7 Million CNY | 16.95% |
| 2018 Q1 | 76.7 Million CNY | -27.21% |
| 2018 Q3 | 89.95 Million CNY | 0.28% |
| 2018 FY | 322.76 Million CNY | 1.61% |
| 2018 Q4 | 66.39 Million CNY | -26.19% |
| 2017 Q2 | 77.61 Million CNY | 25.39% |
| 2017 Q4 | 105.38 Million CNY | 44.87% |
| 2017 FY | 317.64 Million CNY | 7.93% |
| 2017 Q1 | 61.9 Million CNY | -22.51% |
| 2017 Q3 | 72.74 Million CNY | -6.28% |
| 2016 Q2 | 72.19 Million CNY | 1.25% |
| 2016 Q3 | 70.91 Million CNY | -1.78% |
| 2016 Q4 | 79.87 Million CNY | 12.64% |
| 2016 FY | 294.29 Million CNY | -25.27% |
| 2016 Q1 | 71.3 Million CNY | -47.5% |
| 2015 Q2 | 88.14 Million CNY | 20.31% |
| 2015 Q4 | 135.82 Million CNY | 40.66% |
| 2015 FY | 393.79 Million CNY | 18.61% |
| 2015 Q3 | 96.56 Million CNY | 9.55% |
| 2015 Q1 | 73.26 Million CNY | -49.86% |
| 2014 FY | 332.01 Million CNY | 52.99% |
| 2014 Q4 | 146.11 Million CNY | 114.06% |
| 2014 Q3 | 68.25 Million CNY | 0.14% |
| 2014 Q2 | 68.16 Million CNY | 37.77% |
| 2014 Q1 | 49.47 Million CNY | 14.9% |
| 2013 Q3 | 64.32 Million CNY | 7.68% |
| 2013 FY | 217.02 Million CNY | 9.8% |
| 2013 Q2 | 59.73 Million CNY | 19.73% |
| 2013 Q4 | 43.06 Million CNY | -33.06% |
| 2013 Q1 | 49.89 Million CNY | -9.89% |
| 2012 Q1 | 39.06 Million CNY | -12.78% |
| 2012 Q2 | 52.03 Million CNY | 33.22% |
| 2012 FY | 197.65 Million CNY | 27.2% |
| 2012 Q3 | 51.18 Million CNY | -1.64% |
| 2012 Q4 | 55.37 Million CNY | 8.17% |
| 2011 Q1 | 30.45 Million CNY | 0.0% |
| 2011 Q3 | 38.52 Million CNY | -7.43% |
| 2011 Q2 | 41.61 Million CNY | 36.66% |
| 2011 FY | 155.38 Million CNY | 29.25% |
| 2011 Q4 | 44.78 Million CNY | 16.24% |
| 2010 FY | 120.22 Million CNY | 39.67% |
| 2009 FY | 86.07 Million CNY | 39.11% |
| 2008 FY | 61.87 Million CNY | 0.0% |